Settling pharmaceutical patent litigation through reverse payments: Contrasting views.
Our rough guess is there are 9,500 words in this book.
At a pace averaging 250 words per minute, this book will take 0 hours and 38 minutes to read. With a half hour per day, this will take 1 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Word Count
9,500 words, Guess
Page Count
38 pages
Identifiers
- ISBN-139780494212356
- ISBN-100494212357
- OCLC Control Number427674277
- Open LibraryOL19551685M
Description
The pharmaceutical market in the United States has been facing a severe problem of raising prices, partially because the granting of weak patents increases the number of patent-based monopolies. This problem was partially addressed by the U.S. Congress through the Hatch-Waxman amendments to the Food, Drug and Cosmetics Act which gave generic applicants bonuses for litigating against pharmaceutical patents, which have been used by these applicants and patentees to enter into exclusionary agreements in exchange for a so-called "reverse" payment.In this thesis I propose a new understanding of Hatch-Waxman as a limitation on patent rights which would not permit agreements including reverse payments, and explain why the focus to fully solve this problem should not be left entirely to courts, but instead should be placed on improving granting of patents.
Subjects
Topics
Places
Links
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!